CVS Health (CVS) Tops Q2 EPS by 75c; raises guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $85.89 -1.39%
Revenue Growth %: +1.3%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +1.3%
Financial Fact:
Weighted average basic common shares outstanding (in shares): 1.07B
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q2 EPS of $2.58, $0.75 better than the analyst estimate of $1.83. Revenue for the quarter came in at $106.1 billion versus the consensus estimate of $100.03 billion.
GUIDANCE:
CVS Health sees FY2026 EPS of $7.90-$8.10, versus the consensus of $7.45.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Cintas Corp. (CTAS) Tops Q1 EPS by 1c, Offers Guidance
- eBay (EBAY) call put ratio 1 call 3.6 puts with a focus on 5200 contracts of October 9 weekly 108 puts
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
